World Journal of
Pharmaceutical and Life Sciences

BREAST CANCER IN MEN ABOUT NINE CASES MANAGED AT THE MOHAMED VI CENTER FOR ONCOGYNECOLOGY

Dr. M. Ajbabdi1, Dr. A. Touimi Benjelloun*, Mamadi Kourouma, Prof. Ennachit M. and Prof. Kerroumi

ABSTRACT

Breast cancer in men is a rare disease. Risk factors are many and varied. The diagnosis is made at a later age than in women and at a later stage. The clinical presentation of the disease differs a little in men. All histological varieties can be seen in men with a rarity of lobular carcinoma. Hormonal receptors are often positive with a rare overexpression of her2 in men the sentinel lymph node method is technically possible. Hormone therapy plays an important role in treatment and tamoxifen remains the molecule of choice. The treatment of breast cancer in men is not as well codified as in women. For obtain the logical conclusions, investigators link multi-institutional analyzes, a prospective multicenter trial is currently underway in the US, which sets as its main objective to optimize the therapeutic strategy. The prognosis for breast cancer in men is the same as in women at the same stage. Several studies are needed to optimize the management of patients with this disease. It would be desirable that efforts of education and information of the Moroccan population with regard to this pathology, combined with an adequate psychological management of the patient and his family, be implemented in order to improve the experience and the prognosis of Moroccan patient with breast cancer. In Morocco, the incidence of breast cancer in men is estimated at 0.8 - 1%.

[Full Text Article]   [Download Certificate]